The U.S. FDA has revoked the emergency use authorization for hydroxychloroquine to treat COVID-19.
According to Reuters, following the revocation, the FDA quickly came under fire from President Donald Trump.
Trump said that U.S. agencies have failed to grasp the benefit of the medication in fighting the coronavirus.
Based on evidence, the FDA said it was no longer believes that hydroxychloroquine is effective in treating COVID-19.
The FDA also warned that the hydroxychloroquine has been shown to interfere with the antiviral drug remdesivir.
Remdesivir is the only medicine so far to show a benefit against COVID-19 in formal clinical trials.